Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,831Revenue $M1,173Net Margin (%)18.0Altman Z-Score4.4
Enterprise Value $M11,393EPS $0.9Operating Margin %30.7Piotroski F-Score7
P/E(ttm)52.8Beneish M-Score-2.7Pre-tax Margin (%)26.8Higher ROA y-yY
Price/Book8.310-y EBITDA Growth Rate %--Quick Ratio4.9Cash flow > EarningsY
Price/Sales9.25-y EBITDA Growth Rate %48.7Current Ratio5.0Lower Leverage y-yY
Price/Free Cash Flow38.0y-y EBITDA Growth Rate %59.6ROA % (ttm)6.8Higher Current Ratio y-yY
Dividend Yield %--PEG1.1ROE % (ttm)16.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M61.1ROIC % (ttm)12.2Gross Margin Increase y-yY

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JAZZSteve Mandel 2015-03-31 Reduce-1.12%$158.12 - $189.01
($171.62)
$ 177.373%Reduce 86.14%260,985
JAZZJoel Greenblatt 2015-03-31 Buy 0.01%$158.12 - $189.01
($171.62)
$ 177.373%New holding10,874
JAZZNWQ Managers 2015-03-31 Add$158.12 - $189.01
($171.62)
$ 177.373%Add 0.06%64,824
JAZZKen Fisher 2015-03-31 Buy $158.12 - $189.01
($171.62)
$ 177.373%New holding1,300
JAZZNWQ Managers 2014-12-31 Reduce-0.13%$142.72 - $183.03
($166.14)
$ 177.377%Reduce 53.29%64,783
JAZZSteve Mandel 2014-09-30 Reduce-0.17%$132.55 - $174.37
($153.67)
$ 177.3715%Reduce 14.30%1,788,607
JAZZNWQ Managers 2014-09-30 Reduce-0.1%$132.55 - $174.37
($153.67)
$ 177.3715%Reduce 32.97%138,705
JAZZSteve Mandel 2014-06-30 Reduce-0.15%$124.63 - $154.82
($138.55)
$ 177.3728%Reduce 10.98%2,087,127
JAZZJoel Greenblatt 2014-06-30 Sold Out -0.02%$124.63 - $154.82
($138.55)
$ 177.3728%Sold Out0
JAZZGeorge Soros 2014-06-30 Sold Out $124.63 - $154.82
($138.55)
$ 177.3728%Sold Out0
JAZZSteve Mandel 2014-03-31 Buy 1.4%$125.51 - $174.98
($149.95)
$ 177.3718%New holding2,344,486
JAZZNWQ Managers 2014-03-31 Add0.04%$125.51 - $174.98
($149.95)
$ 177.3718%Add 26.81%173,919
JAZZJoel Greenblatt 2014-03-31 Buy 0.02%$125.51 - $174.98
($149.95)
$ 177.3718%New holding7,367
JAZZGeorge Soros 2014-03-31 Buy $125.51 - $174.98
($149.95)
$ 177.3718%New holding3,600
JAZZJohn Paulson 2013-12-31 Sold Out -0.57%$82.62 - $126.79
($103.31)
$ 177.3772%Sold Out0
JAZZNWQ Managers 2013-12-31 Reduce-0.05%$82.62 - $126.79
($103.31)
$ 177.3772%Reduce 29.02%137,154
JAZZNWQ Managers 2013-06-30 Buy 0.12%$52.79 - $70.86
($61.12)
$ 177.37190%New holding198,679
JAZZJohn Paulson 2012-09-30 Buy 0.47%$44.4 - $58.5
($48.28)
$ 177.37267%New holding1,000,000
JAZZKen Heebner 2011-12-31 Sold Out -0.09%$34.8 - $44.27
($38.53)
$ 177.37360%Sold Out0
JAZZKen Heebner 2011-09-30 Buy 0.09%$32.7 - $46.8
($39.51)
$ 177.37349%New holding95,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JAZZ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hooper Suzanne SawochkaEVP & General Counsel 2015-06-09Sell4,000$173.162.43view
COZADD BRUCE CChairman & CEO 2015-06-09Sell5,000$173.162.43view
WILSON KAREN JSVP, Finance & PAO 2015-06-02Sell5,751$179.59-1.24view
ENRIGHT PATRICK GDirector 2015-06-01Sell10,000$178.73-0.76view
McGill IainSVP, Europe and Rest of World 2015-05-26Sell7,334$179.48-1.18view
Gray PeterDirector 2015-05-12Sell704$173.862.02view
Hooper Suzanne SawochkaEVP & General Counsel 2015-05-12Sell4,000$173.852.02view
COZADD BRUCE CChairman & CEO 2015-05-12Sell5,000$173.852.02view
O'Keefe Kenneth WDirector 2015-05-12Sell1,218$174.91.41view
RIEDEL NORBERT GDirector 2015-05-12Sell650$173.862.02view

Quarterly/Annual Reports about JAZZ:

News about JAZZ:

Articles On GuruFocus.com
luca May 30 2015 
Weekly Insider Sells Highlight: MHK, JAZZ, BMY, ZAYO Mar 23 2015 
Pharmaceutical Giant Merck Buys Cubist Pharma Dec 09 2014 
Growth Momentum Should Continue For This Pharmaceutical Company Nov 15 2014 
Jazz Pharmaceuticals: Growth Trajectory Can Continue In Future Sep 03 2014 
Weekly CFO Sells Highlight: Google Inc, Jazz Pharmaceuticals PLC, Jack in the Box Inc. Jun 30 2014 
Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI Mar 11 2014 
Weekly CFO Sells Highlight: Jazz Pharmaceuticals PLC, Carnival PLC, Juniper Networks Inc., Home Depo Mar 10 2014 
comment on JAZZ Mar 21 2013 
optimized portfolio Jul 26 2011 

More From Other Websites
Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 Jul 01 2015
Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 Jul 01 2015
Why Jazz Pharmaceuticals Is Winning Jun 29 2015
Jazz Pharma Still Loved At UBS, Firm Hikes Price Target To $210 Jun 29 2015
Jazz Financing I Ltd. -- Moody's assigns Ba2 to Jazz's new senior secured bank facilities; stable... Jun 19 2015
JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination... Jun 18 2015
Should Active Managers Blame the Benchmark? Jun 15 2015
Edited Transcript of JAZZ presentation 10-Jun-15 5:40pm GMT Jun 11 2015
Jazz Pharmaceuticals' Sleep Disorder Drug Enters Phase III - Analyst Blog Jun 09 2015
Aytu BioScience Acquires Commercial-Stage Prostate Cancer Biologic Jun 09 2015
Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Clinical Development Program... Jun 08 2015
Jazz Pharmaceuticals to Present Abstracts from Ongoing Evaluations of Xyrem® (sodium oxybate) at... Jun 04 2015
Jazz Pharmaceuticals to Present Abstracts from Ongoing Evaluations of Xyrem® (sodium oxybate) at... Jun 04 2015
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences May 15 2015
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences May 15 2015
JAZZ PHARMACEUTICALS PLC Financials May 15 2015
Jazz Pharmaceuticals Misses on Q1 Earnings, Affirms View - Analyst Blog May 08 2015
Jazz Pharmaceuticals (JAZZ) Earnings Report: Q1 2015 Conference Call Transcript May 08 2015
Jazz misses Street 1Q forecasts May 07 2015
Jazz misses Street 1Q forecasts May 07 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK